Fundraising Fox지엘팜텍
Seongnam, KR · 1 known investors
Find your way into 지엘팜텍
Sign up to see every warm intro you have to 지엘팜텍
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 지엘팜텍 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GLPharmTech is a pharmaceutical company that develops modified-release drug formulations, including Kabalin CR (pregabalin extended-release), for treating neuropathic pain conditions such as diabetic peripheral neuropathy and postherpetic neuralgia.
Founders & leadership
진
진성필Co-representative (CEO)
김
김용일Co-representative (CEO)
JS
Jin Sung-pil
KY
Kim Yong-il
Investors · 1
Frequently asked questions
- What does 지엘팜텍 do?
- GLPharmTech is a pharmaceutical company that develops modified-release drug formulations, including Kabalin CR (pregabalin extended-release), for treating neuropathic pain conditions such as diabetic peripheral neuropathy and postherpetic neuralgia.
- Who are 지엘팜텍's investors?
- 지엘팜텍's investors include Solidus Investment.
- Where is 지엘팜텍 headquartered?
- 지엘팜텍 is headquartered in Seongnam, KR.